Who
H. Stewart Parker
Director
Company insider
Files Form 4 as: Director, Codexis; Director, Sangamo Therapeutics; Director, Impel Pharmaceuticals; Director, Achieve Life Sciences; President & CEO, Armata Pharmaceuticals; Director, Neose Technologies.
In numbers
- Trades disclosed
- 87
- Buys
- 6
- Sells
- 0
- Bought
- $129K
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 4 May 2006
- Last trade
- 17 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 18 Jun 2026 | CDXS Codexisoption or derivative · Chemicals | SEC FORM 4 Code A | —66,350 at $0.00 | filing |
| 17 Jun 2026filed 18 Jun 2026 | CDXS Codexisoption or derivative · Chemicals | SEC FORM 4 Code A | —66,350 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | Sangamo Therapeutics | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | CDXS CodexisChemicals | SEC FORM 4 Code A | —40,983 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CDXS CodexisChemicals | SEC FORM 4 Code A | —30,120 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | Sangamo Therapeutics | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | CDXS CodexisChemicals | SEC FORM 4 Code A | —34,602 at $0.00 | filing |
| 1 Jun 2023filed 5 Jun 2023 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —27,750 at $0.00 | filing |
| 1 Jun 2023filed 5 Jun 2023 | Sangamo Therapeutics | SEC FORM 4 Code A | —13,900 at $0.00 | filing |
| 16 Dec 2022filed 20 Dec 2022 | CDXS CodexisChemicals | SEC FORM 4 Code A | —37,878 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | Impel Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —12,789 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | Sangamo Therapeutics | SEC FORM 4 Bought | $18K5,000 at $3.60 | filing |
| 25 Feb 2022filed 1 Mar 2022 | Sangamo Therapeuticsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 25 Feb 2022filed 1 Mar 2022 | Sangamo Therapeutics | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 11 Jul 2021filed 13 Jul 2021 | Impel Neuropharmaoption or derivative | SEC FORM 4 Code A | —11,500 at $0.00 | filing |
| 27 Apr 2021filed 29 Apr 2021 | Impel Neuropharma | SEC FORM 4 Code C | —3,732 | filing |
| 27 Apr 2021filed 29 Apr 2021 | Impel Neuropharma | SEC FORM 4 Code C | —7,355 | filing |
| 27 Apr 2021filed 29 Apr 2021 | Impel Neuropharma | SEC FORM 4 Code J | —458 at $0.00 | filing |
News
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026ACHV · manilatimes.net · 21 Oct 2026
0 headlines in the last 90 days name H. Stewart Parker; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.